Takeda Pharmaceutical Company Limited
0
0
0%

Financials

Income statement

Fundamentals currency is JPY
Fiscal date 2025 2024 2023 2022
Total reported revenue 25.0B 4.3T 4.0T 3.6T
Cost of revenue 8.6B 1.4T 1.2T 1.1T
Gross profit 16.4B 2.8T 2.8T 2.5T
Operating expense
Research & development 4.0B 729.9B 633.3B 526.1B
Selling general and admin 6.0B 1.1T 997.3B 886.4B
Other operating expenses 202.5M 80.3B 55.4B 30.8B
Operating income 2.7B 321.0B 554.9B 546.0B
Non operating interest income
Income 107.3M 11.3B 5.5B 4.6B
Expense 750.6M 119.5B 117.0B 122.4B
Other income expense -925.5M -127.7B -56.4B -120.0B
Pretax income 957.0M 52.8B 375.1B 302.6B
Tax provision 365.9M -91.4B 58.1B 72.4B
Net income 591.1M 144.2B 317.0B 230.2B
Basic EPS 68.4 92.1 204.3 147.1
Diluted EPS 67.2 91.2 201.9 145.9
Basic average shares 8.6M 1.6B 245.1B 246.9B
Diluted average shares 8.6M 1.6B 245.1B 246.9B
EBITDA 6.8B 1.0T 1.2T 1.1T
Net income from continuing op. 591.1M 144.2B 317.0B 230.2B
Minority interests -215M -130M -21M -107M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 5 minutes

12:29
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).